Trans-Nerolidol
Trans-Nerolidol improves the anti-proliferative effect of Doxorubicin (DOX) (HY-15142A) against intestinal cancer and breast cancer cells in vitro. trans-Nerolidol increases accumulation of DOX inside cells in vitro. trans-Nerolidol activates apoptosis in vivo[1].
Product Specifications
CAS Number
[40716-66-3]
UNSPSC
12352211
Hazard Statement
H317, H319, H410
Target
Fungal
Type
Natural Products
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Infection
Assay Protocol
https://www.medchemexpress.com/trans-nerolidol.html
Purity
97.58
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
C=CC(C)(O)CC/C=C(C)/CC/C=C(C)/C
Molecular Formula
C15H26O
Molecular Weight
222.37
Precautions
H317, H319, H410
References & Citations
[1]Hanušová V, et al. The effects of β-caryophyllene oxide and trans-nerolidol on the efficacy of doxorubicin in breast cancer cells and breast tumor-bearing mice. Biomed Pharmacother. 2017 Nov;95:828-836.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, stored under nitrogen)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
NBP3-24314AF750 0.1 mL
Mouse Monoclonal Melan-A/MART-1 Antibody (rMLANA/9404) [Alexa Fluor 750]
Ask
View Details MBS636584-01 0.002 mg
Ephrin B3, Recombinant, Human (EFNB3, Ephrin B3 (EFL6, EPH-related receptor transmembrane ligand ELK-L3, EPH-related receptor tyrosine kinase ligand 8, Ephrin-B3, EPLG8, LERK8)
Ask
View Details MBS636584-02 0.005 mg
Ephrin B3, Recombinant, Human (EFNB3, Ephrin B3 (EFL6, EPH-related receptor transmembrane ligand ELK-L3, EPH-related receptor tyrosine kinase ligand 8, Ephrin-B3, EPLG8, LERK8)
Ask
View Details